JEREMÍAS BUSTOS; JEREMÍAS DUTTO; JIMENA TOSELLO; PILAR BIASI; SABRINA DHOOGE; ANA PAULA FLORES GUIRADO; LUCIA BOFFELLI; NICOLÁS NÚÑEZ; MARIANA MACCIONI

Single Cell Proteomic and transcriptomic analysis of the tonsillar B cells from pediatric Down syndrome donors reveal enhanced antiviral transcriptomic programs.

4th Franco Argentine Immunology Congress

Lugar: Buenos Aires; Año: 2025;

PILAR BIASI; LUCIA BOFFELLI; FIAMMA BERNER; EKATERINA FRIEBEL; JEREMÍAS BUSTOS; SABRINA DHOOGE; JEREMÍAS DUTTO; ANA PAULA FLORES GUIRADO; BURKHARD BECHER; LUKAS FLATZ; MARIANA MACCIONI; NICOLÁS NÚÑEZ

Distinct Cytokine Signatures of Toxicity In Anti-PD-1/CTLA-4 Therapy Not Observed With Anti-PD-1 Monotherapy

4th Franco Argentine Immunology Congress

Lugar: Buenos Aires; Año: 2025;

JEREMÍAS DUTTO; LUCIA BOFFELLI; SABRINA DHOOGE; PAULA ARAYA; JIMENA TOSELLO; ANA PAULA FLORES GUIRADO; JEREMÍAS BUSTOS; PILAR BIASI; CARINA VALERIANI; ELIANE PIAGGIO; JOAQUIN ESPINOSA; NICOLÁS NÚÑEZ; MARIANA MACCIONI

Immune dysregulation in children with Down Syndrome: Single-cell multi-omics reveal Th1-Skewed CD4 differentiation, reduced mature Tfh, and altered tonsillar architecture

4th Franco Argentine Immunology Congress

Lugar: Buenos Aires; Año: 2025;

SABRINA DHOOGE; EKATERINA FRIEBEL; LUCIA BOFFELLI; JEREMÍAS DUTTO; ANA PAULA FLORES GUIRADO; JEREMÍAS BUSTOS; PILAR BIASI; SILVANA MOURON; MIGUEL QUINTELA-FANDINO; BURKHARD BECHER; MARIANA MACCIONI; NICOLÁS NÚÑEZ

Peripheral and Tumor Immune Signatures Predict Response to Immunotherapy in Advanced HER2-negative Breast Cancer

4th Franco Argentine Immunology Congress

Lugar: Buenos Aires; Año: 2025;

ANA PAULA FLORES GUIRADO; SABRINA DHOOGE; LUCIA BOFFELLI; JEREMÍAS DUTTO; JEREMÍAS BUSTOS; PILAR BIASI; EVA A. ACOSTA RODRIGUEZ; GABRIEL MORÓN; BELKYS A. MALETTO; BURKHARD BECHER; MARIANA MACCIONI; NICOLÁS NÚÑEZ

Homologous and heterologous COVID-19 vaccines imprint distinct innate immune signatures consistent with trained immunity

4th Franco Argentine Immunology Congress

Lugar: Buenos Aires; Año: 2025;